Gibco™ Glasgow's MEM

Description

Glasgow's Minimum Essential Medium (GMEM) was originally developed by Ian McPherson and Michael Stoker as a modification of Eagle's medium. It was utilized to study the genetic factors which affected cell competence. Glasgow's MEM was developed for use with kidney cells lines, such as BHK-21.

Glasgow's MEM is unique from other media as it contains twice the concentration of amino acids and vitamins than the original Basal Medium Eagle, and is used without serum. Glasgow's MEM was originally formulated with 10% tryptose phosphate broth.

Product Intended Use
For in vitro diagnostic use. CAUTION: Not for human or animal therapeutic use. Uses other than the intended use may be a violation of local law.

Dual-Site cGMP Manufacturing
Gibco™ Glasgow's MEM is manufactured at a cGMP compliant facility, located in Paisley, Scotland, UK. The facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard. For supply chain continuity, we offer a comparable Gibco™ Glasgow's MEM product made in our Grand Island facility (11710-035). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standards.

Glasgow's MEM contains no proteins, lipids, or growth factors. Therefore, Glasgow's MEM requires supplementation, commonly with 10% tryptose phosphate broth. Glasgow's MEM uses a sodium bicarbonate buffer system (2.75 g/L) and therefore requires a 5-10% CO₂ environment to maintain physiological pH.